SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022978
Filing Date
2016-08-05
Accepted
2016-08-05 16:06:05
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnat-10q_20160630.htm 10-Q 837167
2 EX-31.1 cnat-ex311_6.htm EX-31.1 10756
3 EX-31.2 cnat-ex312_8.htm EX-31.2 11933
4 EX-32.1 cnat-ex321_11.htm EX-32.1 6593
5 EX-32.2 cnat-ex322_9.htm EX-32.2 7458
  Complete submission text file 0001564590-16-022978.txt   3189004

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnat-20160630.xml EX-101.INS 630783
7 XBRL TAXONOMY EXTENSION SCHEMA cnat-20160630.xsd EX-101.SCH 23361
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20160630_cal.xml EX-101.CAL 30720
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20160630_def.xml EX-101.DEF 66504
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20160630_lab.xml EX-101.LAB 212583
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20160630_pre.xml EX-101.PRE 154924
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 161811190
SIC: 2834 Pharmaceutical Preparations